免疫检查点-话题@MedSci

#免疫检查点#

164篇内容 | 4167人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1340609, encodeId=b5861340609eb, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Front Oncol：免疫检查点抑制剂（ICI）治疗后出现内分泌不良反应可能疗效更好, objectType=article, longId=301737, objectId=fed4301e37d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fed4301e37d0, replyNumber=0, likeNumber=93, createdTime=2022-03-28, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fed4301e37d0, moduleTitle=Front Oncol：免疫检查点抑制剂（ICI）治疗后出现内分泌不良反应可能疗效更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fed4301e37d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340608, encodeId=2d89134060876, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=JAAD：免疫检查点抑制剂介导的银屑病治疗, objectType=article, longId=301386, objectId=1dbe30138633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dbe30138633, replyNumber=0, likeNumber=130, createdTime=2022-03-23, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dbe30138633, moduleTitle=JAAD：免疫检查点抑制剂介导的银屑病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dbe30138633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340607, encodeId=f98d134060e63, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Cancer Discovery：新型免疫检查点：可用来增强T细胞抗癌，还能让CAR-T对抗实体瘤, objectType=article, longId=300537, objectId=249330053eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=249330053eae, replyNumber=0, likeNumber=91, createdTime=2022-03-13, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=249330053eae, moduleTitle=Cancer Discovery：新型免疫检查点：可用来增强T细胞抗癌，还能让CAR-T对抗实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=249330053eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340606, encodeId=8e5f134060606, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Diabetes Care：免疫检查点抑制剂与1型糖尿病风险, objectType=article, longId=300377, objectId=6ed53003e7f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ed53003e7f1, replyNumber=0, likeNumber=84, createdTime=2022-03-11, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ed53003e7f1, moduleTitle=Diabetes Care：免疫检查点抑制剂与1型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ed53003e7f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340605, encodeId=0d9a134060549, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=J Immunother Cancer：较低的自身抗体水平与免疫检查点抑制剂引起的免疫相关不良事件相关性研究, objectType=article, longId=299379, objectId=a0c12993e948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0c12993e948, replyNumber=0, likeNumber=77, createdTime=2022-02-23, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0c12993e948, moduleTitle=J Immunother Cancer：较低的自身抗体水平与免疫检查点抑制剂引起的免疫相关不良事件相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0c12993e948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340604, encodeId=24341340604e7, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=NK细胞的免疫检查点, objectType=article, longId=295518, objectId=c4a52955189c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a52955189c, replyNumber=0, likeNumber=83, createdTime=2022-02-14, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a52955189c, moduleTitle=NK细胞的免疫检查点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a52955189c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340603, encodeId=284f1340603c5, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, objectType=article, longId=295059, objectId=afe5295059f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe5295059f2, replyNumber=0, likeNumber=57, createdTime=2022-02-04, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe5295059f2, moduleTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afe5295059f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340602, encodeId=2d75134060229, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Clinical Lung Cancer：新冠疫情影响下免疫检查点抑制剂（ICI）的延迟给药并不影响NSCLC患者的疗效, objectType=article, longId=294168, objectId=9ceb29416816, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ceb29416816, replyNumber=0, likeNumber=61, createdTime=2022-01-20, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ceb29416816, moduleTitle=Clinical Lung Cancer：新冠疫情影响下免疫检查点抑制剂（ICI）的延迟给药并不影响NSCLC患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ceb29416816)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340601, encodeId=d415134060147, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据, objectType=article, longId=294051, objectId=55f229405108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55f229405108, replyNumber=0, likeNumber=67, createdTime=2022-01-17, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55f229405108, moduleTitle=BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55f229405108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340600, encodeId=36b8134060060, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征, objectType=article, longId=293979, objectId=c08c2939e93e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c08c2939e93e, replyNumber=0, likeNumber=89, createdTime=2022-01-16, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c08c2939e93e, moduleTitle=Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c08c2939e93e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340599, encodeId=334413405990c, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍, objectType=article, longId=293793, objectId=02ce293e9390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02ce293e9390, replyNumber=0, likeNumber=72, createdTime=2022-01-12, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02ce293e9390, moduleTitle=NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02ce293e9390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340598, encodeId=52ed13405981b, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性, objectType=article, longId=292745, objectId=425c292e45ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=425c292e45ea, replyNumber=0, likeNumber=87, createdTime=2021-12-26, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=425c292e45ea, moduleTitle=Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=425c292e45ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340596, encodeId=ab7b1340596dc, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=J Immunother Cancer：癌症患者COVID- 19灭活疫苗对血清转换的免疫检查点抑制剂的影响和Nomogram预测, objectType=article, longId=292196, objectId=04b42921962d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04b42921962d, replyNumber=0, likeNumber=81, createdTime=2021-12-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04b42921962d, moduleTitle=J Immunother Cancer：癌症患者COVID- 19灭活疫苗对血清转换的免疫检查点抑制剂的影响和Nomogram预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04b42921962d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340597, encodeId=7e3b134059ed1, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Thorac Cancer：EGFR突变肺癌EGFR-TKIs治疗进展后应用免疫检查点抑制剂治疗的疗效, objectType=article, longId=291958, objectId=864c29195801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=864c29195801, replyNumber=0, likeNumber=72, createdTime=2021-12-17, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=864c29195801, moduleTitle=Thorac Cancer：EGFR突变肺癌EGFR-TKIs治疗进展后应用免疫检查点抑制剂治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=864c29195801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340595, encodeId=da69134059558, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, objectType=article, longId=221539, objectId=ea642215396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea642215396a, replyNumber=0, likeNumber=57, createdTime=2021-12-06, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea642215396a, moduleTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea642215396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340594, encodeId=4be1134059428, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Hepatology：皮质类固醇剂量对免疫检查点抑制剂治疗肝炎的结局影响, objectType=article, longId=221275, objectId=f2552212e5e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2552212e5e3, replyNumber=0, likeNumber=82, createdTime=2021-12-01, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2552212e5e3, moduleTitle=Hepatology：皮质类固醇剂量对免疫检查点抑制剂治疗肝炎的结局影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2552212e5e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340593, encodeId=c2e113405935d, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Clin Lymphoma Myeloma Leuk：接受免疫检查点抑制剂治疗的 AML 患者的感染并发症, objectType=article, longId=221212, objectId=7f77221212e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f77221212e6, replyNumber=0, likeNumber=78, createdTime=2021-11-30, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f77221212e6, moduleTitle=Clin Lymphoma Myeloma Leuk：接受免疫检查点抑制剂治疗的 AML 患者的感染并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f77221212e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340592, encodeId=b10c13405920e, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, objectType=article, longId=220996, objectId=8ab722099677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab722099677, replyNumber=0, likeNumber=95, createdTime=2021-11-26, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab722099677, moduleTitle=Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab722099677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340591, encodeId=f3e6134059144, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Front Oncol：回顾性分析实体恶性肿瘤伴有脑转移患者从免疫检查点抑制剂治疗的获益情况, objectType=article, longId=220855, objectId=b2bf220855c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2bf220855c8, replyNumber=0, likeNumber=71, createdTime=2021-11-24, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2bf220855c8, moduleTitle=Front Oncol：回顾性分析实体恶性肿瘤伴有脑转移患者从免疫检查点抑制剂治疗的获益情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2bf220855c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1340590, encodeId=839e1340590b1, content=<a href='/topic/show?id=dd1a29055c8' target=_blank style='color:#2F92EE;'>#免疫检查点#</a>, objectTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, objectType=article, longId=220495, objectId=dbd22204957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbd22204957c, replyNumber=0, likeNumber=65, createdTime=2021-11-18, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbd22204957c, moduleTitle=Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbd22204957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫检查点

2020-05-29

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Front Oncol：免疫检查点抑制剂（ICI）治疗后出现内分泌不良反应可能疗效更好

2022-03-28

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

JAAD：免疫检查点抑制剂介导的银屑病治疗

2022-03-23

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Cancer Discovery：新型免疫检查点：可用来增强T细胞抗癌，还能让CAR-T对抗实体瘤

2022-03-13

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Diabetes Care：免疫检查点抑制剂与1型糖尿病风险

2022-03-11

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

J Immunother Cancer：较低的自身抗体水平与免疫检查点抑制剂引起的免疫相关不良事件相关性研究

2022-02-23

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

NK细胞的免疫检查点

2022-02-14

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效

2022-02-04

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Clinical Lung Cancer：新冠疫情影响下免疫检查点抑制剂（ICI）的延迟给药并不影响NSCLC患者的疗效

2022-01-20

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

BMC Cancer：西方真实世界数据为免疫检查点抑制剂在经治转移性胃癌患者的疗效再添证据

2022-01-17

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Nat Med：黑色素瘤患者与免疫检查点阻断毒性相关的T细胞特征

2022-01-16

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍

2022-01-12

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Cancer Immunol Immunother：免疫检查点抑制剂(ICIs)联合瑞戈非尼（regorafenib）治疗晚期或转移性微卫星稳定（MSS）结直肠癌的疗效和安全性

2021-12-26

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

J Immunother Cancer：癌症患者COVID- 19灭活疫苗对血清转换的免疫检查点抑制剂的影响和Nomogram预测

2021-12-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Thorac Cancer：EGFR突变肺癌EGFR-TKIs治疗进展后应用免疫检查点抑制剂治疗的疗效

2021-12-17

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效

2021-12-06

智智灵药 (审核中...)

前往app查看评论内容

#免疫检查点#

Hepatology：皮质类固醇剂量对免疫检查点抑制剂治疗肝炎的结局影响

2021-12-01

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Clin Lymphoma Myeloma Leuk：接受免疫检查点抑制剂治疗的 AML 患者的感染并发症

2021-11-30

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Thorac Cancer：真实世界中中国非小细胞肺癌（NSCLC）伴有脑转移（BM）患者使用免疫检查点抑制剂（ICIs）的疗效

2021-11-26

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Front Oncol：回顾性分析实体恶性肿瘤伴有脑转移患者从免疫检查点抑制剂治疗的获益情况

2021-11-24

ms5187542471278033 (审核中...)

前往app查看评论内容

#免疫检查点#

Front Oncol：Lenvatinib(仑伐替尼，LEN)联合免疫检查点抑制剂(ICIs)治疗晚期肝细胞癌（HCC）患者的安全性和有效性

2021-11-18

科室
- - 订阅+
  - 更多科室
工具
服务